Abstract
Introduction
Onyx and ethanol are well-known embolic and sclerotic agents that are frequently used in embolization. These agents present advantages and disadvantages regarding visibility, injection control and penetration depth. Mixing both products might yield a new product with different characteristics. The aim of this study is to evaluate the injectability, radiopacity, and mechanical and occlusive properties of different mixtures of Onyx 18 and ethanol in vitro and in vivo (in a swine model).
Materials and Methods
Various Onyx 18 and ethanol formulations were prepared and tested in vitro for their injectability, solidification rate and shrinkage, cohesion and occlusive properties. In vivo tests were performed using 3 swine. Ease of injection, radiopacity, cohesiveness and penetration were analyzed using fluoroscopy and high-resolution CT.
Results
All mixtures were easy to inject through a microcatheter with no resistance or blockage in vitro and in vivo. The 50%-ethanol mixture showed delayed copolymerization with fragmentation and proximal occlusion. The 75%-ethanol mixture showed poor radiopacity in vivo and was not tested in vitro. The 25%-ethanol mixture showed good occlusive properties and accepted penetration and radiopacity.
Conclusion
Mixing Onyx and ethanol is feasible. The mixture of 25% of ethanol and 75% of Onyx 18 could be a new sclero-embolic agent. Further research is needed to study the chemical changes of the mixture, to confirm the significance of the added sclerotic effect and to find out the ideal mixture percentages.
Similar content being viewed by others
References
Cho SK, Do YS, Shin SW, Kim D-I, Kim YW, Park KB, et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006;13:527–38.
Do YS, Yakes WF, Shin SW, Lee B-B, Kim D-I, Liu WC, et al. Ethanol embolization of arteriovenous malformations: interim results 1. Radiology. 2005;235:674–82.
Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47:1292–9.
Elhammady MS, Peterson EC, Johnson JN, Aziz-Sultan MA. Preoperative onyx embolization of vascular head and neck tumors by direct puncture. World Neurosurg. 2011 [cited 2011 Nov 20]; http://www.ncbi.nlm.nih.gov/pubmed/22079824.
Gomes AS. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches. Radiology. 1994;190:191–8.
Do YS, Park K-B, Cho SK. How do we treat arteriovenous malformations (tips and tricks)? Tech Vasc Interv Radiol. 2007;10:291–8.
Houbballah R, Mallios A, Poussier B, Soury P, Fukui S, Gigou F, et al. A new therapeutic approach to congenital pelvic arteriovenous malformations. Ann Vasc Surg. 2010;24:1102–9.
Jeong H-S, Baek C-H, Son Y-I, Wook Kim T, Bung Lee B, Sik Byun H. Treatment for extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol (Stockh). 2006;126:295–300.
Kademani D, Costello BJ, Ditty D, Quinn P. An alternative approach to maxillofacial arteriovenous malformations with transosseous direct puncture embolization. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:701–6.
Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol. 1996;19:323–8.
Loh Y, Duckwiler GR. Onyx trial investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2010;113:733–41.
Ayad M, Eskioglu E, Mericle RA. Onyx: a unique neuroembolic agent. Expert Rev Med Devices. 2006;3:705–15.
Saeed Kilani M, Izaaryene J, Cohen F, Varoquaux A, Gaubert JY, Louis G, et al. Ethylene vinyl alcohol copolymer (Onyx®) in peripheral interventional radiology: indications, advantages and limitations. Diagn Interv Imaging. 2015;96:319–26.
Ambekar S, Gaynor BG, Peterson EC, Elhammady MS. Long-term angiographic results of endovascularly “cured” intracranial dural arteriovenous fistulas. J Neurosurg. 2016;124:1123–7.
Jacobowitz GR, Rosen RJ, Rockman CB, Nalbandian M, Hofstee DJ, Fioole B, et al. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up. J Vasc Surg. 2001;33:51–5.
Soulez G, Lerouge S, Darsaut T, Salazkin I, Oliva VL, Raymond J. Role of the endothelial lining in endoleak formation and persistence after endovascular repair of aneurysm. J Vasc Interv Radiol. 2008;19:1070–8.
Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Interv Radiol. 2010;27:391–9.
Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics. 2005;25:S159–71.
Ellman BA, Parkhill BJ, Marcus PB, Curry TS, Peters PC. Renal ablation with absolute ethanol. Mechanism of action. Invest Radiol. 1984;19:416–23.
Yakes WS, Parker SH. Diagnosis and management of vascular anomalies. Interv Radiol. Baltimore: Williams and Wilkins; 1992. p. 152–89.
Do YS, Park KB, Park HS, Cho SK, Shin SW, Moon JW, et al. Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol JVIR. 2010;21:807–16.
Katz JM, Gobin YP, Riina HP. Interv Neuroradiol. New York: Informa; 2008. p. 161–82.
Fatimi A, Chabrot P, Berrahmoune S, Coutu J-M, Soulez G, Lerouge S. A new injectable radiopaque chitosan-based sclerosing embolizing hydrogel for endovascular therapies. Acta Biomater. 2012;8:2712–21.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Gilles Soulez: Dr. Soulez reports grants from Cook Medical, grants from Biotronik Medical, from Siemens Medical, outside the submitted work; in addition, Dr. Soulez has a patent null licensed to Cook Medical.
Additional information
Fatemeh Zehtabi: Co-first author
Rights and permissions
About this article
Cite this article
Saeed Kilani, M., Zehtabi, F., Lerouge, S. et al. New Alcohol and Onyx Mixture for Embolization: Feasibility and Proof of Concept in Both In Vitro and In Vivo Models. Cardiovasc Intervent Radiol 40, 735–743 (2017). https://doi.org/10.1007/s00270-016-1559-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-016-1559-z